生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Metronidazole is an orally active nitroimidazole antibiotic known for its ability to cross the blood-brain barrier. It is primarily used in the research of anaerobic infections due to its efficacy against a range of anaerobic bacteria and protozoa[1].[2].[3].[4]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02735395 | Chronic Periodontitis | Phase 4 | Active, not recruiting | September 2018 | Brazil ... 展开 >> Guarulhos University Guarulhos, São Paulo, Brazil, 07023-070 收起 << |
NCT03169946 | Periodontal and Endodontic Les... 展开 >>ion 收起 << | Not Applicable | Active, not recruiting | September 2017 | - |
NCT02736682 | Post Operative Infections | Phase 4 | Completed | - | Uganda ... 展开 >> Mulago National Refferal Hospital Kampala, Uganda, 00256 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
5.84mL 1.17mL 0.58mL |
29.21mL 5.84mL 2.92mL |
58.43mL 11.69mL 5.84mL |
参考文献 |
---|
[1]Scully BE. Metronidazole. Med Clin North Am. 1988 May;72(3):613-21. |